Rare
lephants
Screener
Toggle theme
Harrow, Inc.
HROW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2023
FY2022
FY2021
FY2019
FY2018
Total Cash from Operations:
$22.9M
Line Item
Value
% of Total
Capital Expenditures
$1.8M
7.7%
Other Investing
$431.0K
1.9%
Working Capital
$18.0M
78.9%
Net Cash Flow
$2.6M
11.5%
Download CSV
